187 related articles for article (PubMed ID: 9649137)
41. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
42. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
[TBL] [Abstract][Full Text] [Related]
43. [Genomic profile in high risk neuroblastoma by comparative genomic hybridization].
Noguera Salvá R; Piqueras Franco M; Ruiz Saurí A; Llombart-Bosch A; Castel Sánchez V; Navarro Fos S
An Pediatr (Barc); 2006 May; 64(5):449-56. PubMed ID: 16756886
[TBL] [Abstract][Full Text] [Related]
44. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
Vandesompele J; Baudis M; De Preter K; Van Roy N; Ambros P; Bown N; Brinkschmidt C; Christiansen H; Combaret V; Lastowska M; Nicholson J; O'Meara A; Plantaz D; Stallings R; Brichard B; Van den Broecke C; De Bie S; De Paepe A; Laureys G; Speleman F
J Clin Oncol; 2005 Apr; 23(10):2280-99. PubMed ID: 15800319
[TBL] [Abstract][Full Text] [Related]
45. Aberrant methylation of multiple genes in neuroblastic tumours. relationship with MYCN amplification and allelic status at 1p.
Gonzalez-Gomez P; Bello MJ; Lomas J; Arjona D; Alonso ME; Amiñoso C; Lopez-Marin I; Anselmo NP; Sarasa JL; Gutierrez M; Casartelli C; Rey JA
Eur J Cancer; 2003 Jul; 39(10):1478-85. PubMed ID: 12826052
[TBL] [Abstract][Full Text] [Related]
46. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
Ambros PF; Ambros IM; Strehl S; Bauer S; Luegmayr A; Kovar H; Ladenstein R; Fink FM; Horcher E; Printz G
Eur J Cancer; 1995; 31A(4):510-5. PubMed ID: 7576955
[TBL] [Abstract][Full Text] [Related]
47. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
Gehring M; Berthold F; Edler L; Schwab M; Amler LC
Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602
[TBL] [Abstract][Full Text] [Related]
48. New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status.
Simon T; Spitz R; Faldum A; Hero B; Berthold F
J Pediatr Hematol Oncol; 2004 Dec; 26(12):791-6. PubMed ID: 15591897
[TBL] [Abstract][Full Text] [Related]
49. An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas.
Takeda O; Handa M; Uehara T; Maseki N; Sakashita A; Sakurai M; Kanda N; Arai Y; Kaneko Y
Br J Cancer; 1996 Nov; 74(10):1620-6. PubMed ID: 8932344
[TBL] [Abstract][Full Text] [Related]
50. Neuroblastoma tumour genetics: clinical and biological aspects.
Bown N
J Clin Pathol; 2001 Dec; 54(12):897-910. PubMed ID: 11729208
[TBL] [Abstract][Full Text] [Related]
51. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
[TBL] [Abstract][Full Text] [Related]
52. Molecular basis for heterogeneity in human neuroblastomas.
Brodeur GM
Eur J Cancer; 1995; 31A(4):505-10. PubMed ID: 7576954
[TBL] [Abstract][Full Text] [Related]
53. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Łastowska M; Viprey V; Santibanez-Koref M; Wappler I; Peters H; Cullinane C; Roberts P; Hall AG; Tweddle DA; Pearson AD; Lewis I; Burchill SA; Jackson MS
Oncogene; 2007 Nov; 26(53):7432-44. PubMed ID: 17533364
[TBL] [Abstract][Full Text] [Related]
54. Neuroblastoma: a multiple biological disease.
Tonini GP
Eur J Cancer; 1993; 29A(6):802-4. PubMed ID: 8484968
[TBL] [Abstract][Full Text] [Related]
55. Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification.
Souzaki R; Tajiri T; Teshiba R; Kinoshita Y; Yosue R; Kohashi K; Oda Y; Taguchi T
J Pediatr Surg; 2011 Dec; 46(12):2228-32. PubMed ID: 22152855
[TBL] [Abstract][Full Text] [Related]
56. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
Chen QR; Bilke S; Wei JS; Whiteford CC; Cenacchi N; Krasnoselsky AL; Greer BT; Son CG; Westermann F; Berthold F; Schwab M; Catchpoole D; Khan J
BMC Genomics; 2004 Sep; 5():70. PubMed ID: 15380028
[TBL] [Abstract][Full Text] [Related]
57. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
[TBL] [Abstract][Full Text] [Related]
58. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues.
Poremba C; Scheel C; Hero B; Christiansen H; Schaefer KL; Nakayama Ji; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
J Clin Oncol; 2000 Jul; 18(13):2582-92. PubMed ID: 10893290
[TBL] [Abstract][Full Text] [Related]
59. Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization.
Breen CJ; O'Meara A; McDermott M; Mullarkey M; Stallings RL
Cancer Genet Cytogenet; 2000 Jul; 120(1):44-9. PubMed ID: 10913676
[TBL] [Abstract][Full Text] [Related]
60. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]